Daly A.F., Rixhon M., Adam C., et al. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 2006, 91:4769-4775.
Ostrom Q.T., Gittleman H., Farah P., et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 2013, 15(Suppl 2):ii1-ii56.
Zhou Y., Zhang X., Klibanski A. Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma. Mol Cell Endocrinol 2014, 386:16-33.
Melmed S. Pathogenesis of pituitary tumors. Nat Rev Endocrinol 2011, 7:257-266.
Tichomirowa M.A., Daly A.F., Beckers A. Familial pituitary adenomas. J Intern Med 2009, 266:5-18.
Valdes-Socin H.P., Stevens V., Stevenaert A., et al. Adenomes hypophysaires familiaux isoles non lies avec la mutation somatique NEM-1. Suivi de 27 patients. Ann Endocrinol 2000, 61:301.
Daly A.F., Jaffrain-Rea M.L., Ciccarelli A., et al. Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 2006, 91:3316-3323.
Beckers A., Aaltonen L.A., Daly A.F., et al. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 2013, 34:239-277.
Vierimaa O., Georgitsi M., Lehtonen R., et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006, 312:1228-1230.
Daly A.F., Vanbellinghen J.F., Khoo S.K., et al. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 2007, 92:1891-1896.
Verloes A., Stevenaert A., Teh B.T., et al. Familial acromegaly: case report and review of the literature. Pituitary 1999, 1:273-277.
Leontiou C.A., Gueorguiev M., van der Spuy J., et al. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 2008, 93:2390-2401.
Daly A.F., Tichomirowa M.A., Petrossians P., et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 2010, 95:E373-E383.
Jennings J.E., Georgitsi M., Holdaway I., et al. Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene. Eur J Endocrinol 2009, 161:799-804.
Tichomirowa M.A., Lee M., Barlier A., et al. Cyclin dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenomas (FIPA) kindreds. Endocr Relat Cancer 2012, 19(3):233-241.
Villa C., Lagonigro M.S., Magri F., et al. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation. Endocr Relat Cancer 2011, 18:347-356.
Igreja S., Chahal H.S., King P., et al. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat 2010, 31:950-960.
Xekouki P., Mastroyiannis S.A., Avgeropoulos D., et al. Familial pituitary apoplexy as the only presentation of a novel AIP mutation. Endocr Relat Cancer 2013, 20:L11-L14.
Stratakis C.A., Tichomirowa M.A., Boikos S., et al. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet 2010, 78:457-463.
Tichomirowa M.A., Barlier A., Daly A.F., et al. High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol 2011, 165:509-515.
Cazabat L., Bouligand J., Salenave S., et al. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients. J Clin Endocrinol Metab 2012, 97(4):E663-E670.
Cai F., Zhang Y.D., Zhao X., et al. Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis. Eur J Endocrinol 2013, 169:867-884.
Trivellin G., Korbonits M. AIP and its interacting partners. J Endocrinol 2011, 210:137-155.
Cuny T., Pertuit M., Sahnoun-Fathallah M., et al. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis. Eur J Endocrinol 2013, 168:533-541.
